ADHD
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for ADHD as per DSM-5; 2. Meets the diagnostic criteria for Attention-Deficit/Hyperactivity Disorder (ADHD) with TCM syndromes of Heart-Spleen Deficiency or Spleen Deficiency with Liver Exuberance; 3. Aged between 6 and 16 years, gender; 4. No use of medications that may affect the trial and no participation in other clinical trials within the past two weeks; 5. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients clearly diagnosed with epilepsy, autism, chorea, athetosis, intellectual disability, or hepatolenticular degeneration, and those with autoimmune diseases; 2. ADHD caused by other medications or ADHD that has not been clearly defined; 3. Patients with severe organic lesions, genetic metabolic diseases, or infectious diseases; 4. Patients known to be allergic to the investigational drug in this study; 5. Patients who are unable to adhere to the treatment; 6. Other patients deemed unsuitable for clinical trials by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Swanson, Nolan, and Pelham, Version IV Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine (TCM) Syndrome Scale;Attention Assessment Scale; | — |
Countries
China
Contacts
Henan University of Traditional Chinese Medicine First Affiliated Hospital